Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
The Needle-Averse Market is Massive A survey of over 1,000 adults living with obesity found that 71% would prefer a daily pill over a weekly injection when choosing a prescription weight-loss medication
In addition, animal, observational, and genetic studies suggest benefits of GLP-1RAs in people with alcohol use disorder, although randomized trials have produced mixed results, with ongoing trials assessing their effectiveness in those with substance use disorders (SUDs) and mental illnesses
The additional expenses incurred by manufacturers and distributors due to tariffs are, over time, almost always passed down to consumers, leading to higher out-of-pocket costs for medications
doi:10.1080/10408398.2018.1507996
